BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8244575)

  • 1. Serologic response in human papillomavirus-associated invasive cervical cancer.
    Viscidi RP; Sun Y; Tsuzaki B; Bosch FX; Muñoz N; Shah KV
    Int J Cancer; 1993 Nov; 55(5):780-4. PubMed ID: 8244575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
    Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
    Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins.
    Chee YH; Namkoong SE; Kim DH; Kim SJ; Park JS
    Gynecol Oncol; 1995 May; 57(2):226-31. PubMed ID: 7729739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
    Sun Y; Shah KV; Müller M; Muñoz N; Bosch XF; Viscidi RP
    J Clin Microbiol; 1994 Sep; 32(9):2216-20. PubMed ID: 7529250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
    Sun Y; Eluf-Neto J; Bosch FX; Muñoz N; Walboomers JM; Meijer CJ; Shah KV; Clayman B; Viscidi RP
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):935-40. PubMed ID: 10548324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.
    Sasagawa T; Inoue M; Tanizawa O; Yutsudo M; Hakura A
    Jpn J Cancer Res; 1992 Jul; 83(7):705-13. PubMed ID: 1325428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.
    Müller M; Viscidi RP; Sun Y; Guerrero E; Hill PM; Shah F; Bosch FX; Muñoz N; Gissmann L; Shah KV
    Virology; 1992 Apr; 187(2):508-14. PubMed ID: 1312268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response to HPV16 in CIN-III and cervical cancer patients. Case-control studies in Spain and Colombia.
    De Sanjosé S; Hamsíková E; Muñoz N; Bosch FX; Hofmannová V; Gili M; Izarzugaza I; Viladiu P; Tormo MJ; Moreo P; Muñoz MT; Ascunce N; Tafur L; Shah KV; Vonka V
    Int J Cancer; 1996 Mar; 66(1):70-4. PubMed ID: 8608970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.
    Nindl I; Benitez-Bribiesca L; Berumen J; Farmanara N; Fisher S; Gross G; Lopez-Carillo L; Müller M; Tommasino M; Vazquez-Curiel A
    Arch Virol; 1994; 137(3-4):341-53. PubMed ID: 7524466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia.
    Nakagawa M; Stites DP; Farhat S; Sisler JR; Moss B; Kong F; Moscicki AB; Palefsky JM
    J Infect Dis; 1997 Apr; 175(4):927-31. PubMed ID: 9086151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer.
    Ghosh AK; Smith NK; Stacey SN; Glew SS; Connor ME; Arrand JR; Stern PL
    Int J Cancer; 1993 Feb; 53(4):591-6. PubMed ID: 8382193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
    Kadish AS; Ho GY; Burk RD; Wang Y; Romney SL; Ledwidge R; Angeletti RH
    J Natl Cancer Inst; 1997 Sep; 89(17):1285-93. PubMed ID: 9293919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN).
    Mathur SP; Mathur RS; Rust PF; Young RC
    Am J Reprod Immunol; 2001 Oct; 46(4):280-7. PubMed ID: 11642677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses.
    Mizuuchi M; Hirohashi Y; Torigoe T; Kuroda T; Yasuda K; Shimizu Y; Saito T; Sato N
    Exp Mol Pathol; 2012 Feb; 92(1):185-90. PubMed ID: 22032938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
    Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R; López-Contreras M; Cortes RR
    J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia.
    Tjiong MY; Zumbach K; Schegget JT; van der Vange N; Out TA; Pawlita M; Struyk L
    Viral Immunol; 2001; 14(4):415-24. PubMed ID: 11792070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A; Gómez-Lim MA; Weiss-Steider B; la Rosa GP; Hernández-Montes J; Pérez-Saldaña K; Tapia-Guerrero YS; Toledo-Guzmán ME; Santiago-Osorio E; Sanchez-Peña HI; Mora-García Mde L
    Virol J; 2011 Feb; 8():59. PubMed ID: 21306638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study.
    Sarkar AK; Tortolero-Luna G; Follen M; Sastry KJ
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S251-61. PubMed ID: 16188303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.
    Nindl I; Rindfleisch K; Lotz B; Schneider A; Dürst M
    Int J Cancer; 1999 Jul; 82(2):203-7. PubMed ID: 10389753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.